Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Antonio González-Martı́n(Spanish Ovarian Cancer Research Group), Jonathan A. Ledermann(London Cancer), Alexandra Léary(Institut Gustave Roussy), David S.P. Tan(National University of Singapore), E. Bellet(Alleanza Contro il Cancro), Rowan Miller(Queen Mary University of London), Ana Oaknin(Hebron University), Isabelle Ray‐Coquard(Centre Léon Bérard), Philipp Harter(Kliniken Essen-Mitte), Domenica Lorusso(Agostino Gemelli University Polyclinic), Bhavana Pothuri(Gynecologic Oncology Group)
Cited by 381
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|1.1k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757